57 %Youth living with HIV who had self-disclosed reported elevated depressive symptoms at a prevalence of 57%, compared to 30% among those who had not self-disclosed.
KenyaVIH/sidapublié 2021AIDS and behaviorPubMeddocument de 13 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
2 235 evidences · page 57 / 90
57 %Youth living with HIV who had self-disclosed reported elevated depressive symptoms at a prevalence of 57%, compared to 30% among those who had not self-disclosed.
KenyaVIH/sidapublié 2021AIDS and behaviorPubMeddocument de 13 observations
124 cells/μLIn 102 antiretroviral-naïve Kenyan women with advanced HIV-1 infection, the median CD4 count was 124 cells/μL.
KenyaVIH/sidapublié 2013BMC infectious diseaseseurope_pmcdocument de 3 observations
37 %M184I was the most prevalent clinically important HIV drug resistance variant, seen in 37% of ART-naïve women from the Pumwani Sex Worker cohort of Nairobi, Kenya.
KenyaVIH/sidapublié 2022VirusesPubMeddocument de 4 observations
14,3 %Of 1,200 registered cancer cases, 171 cases (14.3%) met clinical strength-of-evidence criteria for association with HIV infection/AIDS.
Kenyacancer (non précisé) · VIH/sidaobservé August 1 to October 31, 2011publié 2014PloS oneeurope_pmcdocument de 4 observations
73,5 %Among 3891 PLHIV with documented IPT treatment outcomes in Kenya between July 2015 and June 2018, follow-up for active tuberculosis at 6-month post-IPT completion was done for 2729 (73.5%).
Kenyatuberculose · VIH/sidaobservé July 2015 to June 2018publié 2020PloS onePubMeddocument de 8 observations
18 US$The mean total unit cost of HIV testing services (HTS) was US$18 in Kenya.
KenyaVIH/sidaobservé 2019publié 2023BMC health services researchPubMeddocument de 11 observations
0,1 %Only 0.1% of AFRICOS participants reported men who have sex with men (MSM) as a risk factor.
KenyaVIH/sidapublié 2022PloS onePubMeddocument de 13 observations
87 %Among people with HIV reporting hazardous alcohol use, the intervention arm had viral suppression of 87% compared with 72% in the control arm.
KenyaVIH/sidapublié 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations
37 %Among 642 HIV-positive female sex workers eligible for IPT evaluation, 236 (37%) were cascade losses.
KenyaVIH/sidaobservé between March 2000 and January 2010publié 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 9 observationsDOI 10.1097/qai.0000000000001461
1 549 participants1549 participants were included in the analysis.
KenyaVIH/sidapublié 2023The lancet. HIVPubMeddocument de 8 observations
21,5 %HIV prevalence increased from 21.5% to 26.2% among widowed women in Siaya County, Kenya between 2011 and 2022.
KenyaVIH/sidaobservé 2011-2022publié 2025BMC public healthPubMeddocument de 12 observations
85 %In the SEARCH Study in rural Kenya and Uganda (2013–2017), 85% of HIV-positive persons had viral suppression at year 2 according to unadjusted estimates.
KenyaVIH/sidaobservé 2013-2017publié 2020Epidemiology (Cambridge, Mass.)PubMeddocument de 8 observations
10 %Among 607 survey responders (86% of 704 seroconverters), 10% of women reported transactional sex as the suspected infection source.
KenyaVIH/sidapublié 2021PloS onePubMeddocument de 16 observations
4 201 individualsAmong 4201 adolescents and youth living with HIV (AYLHIV) in Kenya between January 2016 and December 2017, 1452 (35%) were newly enrolled and 2749 (65%) had been on antiretroviral therapy (ART) for ≥2 years.
KenyaVIH/sidaobservé 2016-2017publié 2023AIDS patient care and STDsPubMeddocument de 5 observations
1 729 per_one_million_T_cellsIn a cohort of Kenyan children (n = 72), the median number of total HIV proviral copies was 1729 per one million T cells between one- and two-years post-ART initiation.
KenyaVIH/sidapublié 2023VirusesPubMeddocument de 3 observations
1,68 RRSuperinfected individuals develop significantly broader neutralizing antibody responses post-superinfection compared to singly infected individuals, with a relative risk of 1.68.
KenyaVIH/sidapublié 2012PLoS pathogenseurope_pmcdocument de 3 observationsDOI 10.1371/journal.ppat.1002611
15,5 %HIV prevalence among pregnant women receiving HIV testing at antenatal care initiation was 15.5% between October 2016 and September 2021.
KenyaVIH/sidaobservé October 2016 to September 2021publié 2024PLoS medicineeurope_pmcdocument de 5 observations
23,2 %Fifty-four (23.2%) patients had virological failure (>1000 copies/mL).
KenyaVIH/sidapublié 2022MedicinePubMeddocument de 7 observations
49 %Personnel accounted for 49% of the costs of integrating assisted partner services (aPS).
KenyaVIH/sidapublié 2022BMC health services researchPubMeddocument de 13 observations
29,4 %Among men who have sex with men living with HIV in Kenya, 29.4% of those who solely met partners via virtual sites (VMSM) were diagnosed and aware of their status.
KenyaVIH/sidaobservé 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 12 observations
The odds of thrombocytopenia were decreased in HIV/malaria co-infection compared to the uninfected group.
Kenyapaludisme · thrombocytopenia · VIH/sidapublié 2023International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 8 observations
18 %Among 4597 enrolled partner participants, 597 (18%) had HIV.
KenyaVIH/sidapublié 2024The Lancet. Global healthPubMeddocument de 7 observations
421 cells/μlAt baseline, the mean CD4 count for HIV mono-infected individuals was 421 cells/μl.
KenyaVIH/sidapublié 2021Pan African Medical JournalOpenAlexdocument de 10 observations
0,37 odds_ratioAnaemia burden was lower in HIV-positive non-injection substance users compared to HIV-negative non-injection substance users, with an odds ratio of 0.37.
Kenyaanémie · VIH/sidapublié 2022African health sciencesPubMeddocument de 7 observations
1,29 timesIn Kenya, caregivers were 1.29 times more likely to receive early infant diagnosis (EID) results by 12 weeks of age with point-of-care (POC) versus laboratory-based EID.
KenyaVIH/sidapublié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 13 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.